USA - NASDAQ:MRVI - US56600D1072 - Common Stock
MRVI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. While MRVI seems to be doing ok healthwise, there are quite some concerns on its profitability. MRVI does not seem to be growing, but still is valued expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -21.71% | ||
ROE | -73.24% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 29.11% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.2 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 5.16 | ||
Quick Ratio | 4.49 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
3.37
-0.15 (-4.26%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 3.99 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 3.24 | ||
P/tB | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -21.71% | ||
ROE | -73.24% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 29.11% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.2 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 47.92% | ||
Cap/Sales | 11.14% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 5.16 | ||
Quick Ratio | 4.49 | ||
Altman-Z | 1.18 |